Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Raw Materials (2023 - 2024)

Historic Raw Materials for Zevra Therapeutics (ZVRA) over the last 2 years, with Q3 2024 value amounting to $4.5 million.

  • Zevra Therapeutics' Raw Materials changed N/A to $4.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q3 2024, Zevra Therapeutics' Raw Materials is $4.5 million.
  • Zevra Therapeutics' Raw Materials' 5-year high stood at $4.8 million during Q2 2024, with a 5-year trough of $2.9 million in Q4 2023.